CHDI Foundation
The CHDI Foundation, Inc., is a United States–based non-profit biomedical foundation that aims to "rapidly discover and develop drugs that delay or slow the progression of Huntington's disease", a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CHDI Foundation, United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
575
Total Open
Publications
328
Total
Citations
28K
Open Access
Percentage
57%
Total
Publications
575
Total Open
Publications
328
Total
Citations
28K
Breakdown
Publisher Open
10%
Both
29%
Other Platform Open
18%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 62%
138
Hybrid 18%
39
No Guarantees 20%
44
Other Platform Open
Domain 75%
204
Institution 21%
58
Other Internet 15%
42
Preprint 12%
33
Public 7%
20
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 203 |
DOI | Other Internet | 41 |
bioRxiv | Preprint | 26 |
Europe PMC | Domain | 23 |
Figshare | Public | 17 |
epfl.ch OAI-PMH Repository | Institution | 8 |
University of Cambridge | Institution | 7 |
Royal Netherlands Academy of Arts and Sciences | Institution | 6 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 6 |
universiteitleiden.nl OAI-PMH Repository | Institution | 5 |